SARATOV FALL MEETING SFM 

© 2026 All Rights Reserved

Use of a linear accelerator in experimental and clinical oncology

Andrew D. Yankevich 1, Alla B. Bucharskaya 2,3
1 - Lomonosov Moscow State University, Moscow, Russia
2 - Saratov State Medical University, Saratov, Russia
3 - Saratov State University, Saratov, Russia

Abstract

Linear accelerators, widely used in nuclear physics, allow to reach high velocities of charged particles, are an integral part (injector) of the accelerator system of colliders.
In recent years, linear accelerators have been actively investigated for tumor treatment in experimental and clinical oncology.
Conventional radiation therapy uses powerful gamma radiation, which effectively destroys the tumor. A significant disadvantage of this technology is unguided radiation, which affects healthy tissues and organs, leading to disability and reduced quality of life of patients.
Linear accelerators are relatively safe in the sense that after the prescribed dose is delivered there will be no X-rays produced.
But, the radiobiology of an extremely high dose rate of radiation has yet to be thoroughly investigated.
The report presents literature data on the application of linear accelerators for solving problems of experimental and clinical oncology.

Speaker

Andrew D. Yankevich
Lomonosov Moscow State University
Russia

Discussion

Ask question